Literature DB >> 8013501

Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms.

B K Madsen1, J F Hansen, K H Stokholm, J Brøns, D Husum, L S Mortensen.   

Abstract

The prognosis, and clinical findings related to prognosis, were examined in a consecutive series of 190 patients under 76 years of age (mean 64 years) with congestive heart failure (CHF). The aetiology of CHF was ischaemic heart disease in 66%, hypertension in 11% and cardiomyopathy in 23%. The 2-year mortality was 32%. Median left ventricular ejection fraction (LVEF) was 0.30, range 0.06 to 0.74. Eight per cent were in New York Heart Association (NYHA) class I, 46% in II, 44% in III and 2% in IV. Multivariate analysis, excluding exercise test variables, revealed seven variables with independent, significant prognostic information, (hazard ratios for death in brackets): ln (natural logarithm) (LVEF) (3.19), NYHA class III+IV (2.72), plasma urea > 7.6 mmol.l-1 (2.22), serum creatinine > 121 mumol.l-1 (2.05), serum sodium < or = 137 mmol.l-1 (2.03), pulmonary congestion on X-ray (1.86), and age > 65 years (1.86). Multivariate analysis, including exercise testing, showed the following variables to contain independent, significant prognostic information: increase in heart rate during maximal exercise < or = 35 min-1 (3.5), ln (LVEF) (3.7), serum creatinine > 121 mumol.l-1 (2.9), maximal exercise time < or = 4 min (2.3), serum sodium < or = 137 mmol.l-1 (2.5), ischaemic heart disease (2.0) and plasma urea > 7.6 mmol.l-1 (1.9). In conclusion, patients with CHF have a high risk of death despite intensive medical treatment. LVEF is a strong predictor of mortality. Both NYHA class and exercise variables have strong independent prognostic information as regards mortality in combination with LVEF, but are mutually exclusive.

Entities:  

Mesh:

Year:  1994        PMID: 8013501     DOI: 10.1093/oxfordjournals.eurheartj.a060495

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

1.  Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.

Authors:  Simon de Denus; Jean-Claude Tardif; Michel White; Martial G Bourassa; Normand Racine; Sylvie Levesque; Anique Ducharme
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

Review 2.  Patient selection in heart failure with preserved ejection fraction clinical trials.

Authors:  Jacob P Kelly; Robert J Mentz; Alexandre Mebazaa; Adriaan A Voors; Javed Butler; Lothar Roessig; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor; Carolyn S P Lam
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

Review 3.  Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.

Authors:  J Feenstra; D E Grobbee; A Mosterd; B H Stricker
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

4.  Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction.

Authors:  N P Nikitin; P H Loh; R de Silva; J Ghosh; O Y Khaleva; K Goode; A S Rigby; F Alamgir; A L Clark; J G F Cleland
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

Review 5.  Congestive heart failure arising from diastolic dysfunction in the presence of normal left-ventricular systolic function.

Authors:  R F Stainback
Journal:  Tex Heart Inst J       Date:  1999

6.  Investigation of standardized administration of anti-platelet drugs and its effect on the prognosis of patients with coronary heart disease.

Authors:  Chao Ding; Jianhua Zhang; Rongcheng Li; Jiacai Wang; Yongcang Hu; Yanyan Chen; Xiannan Li; Yan Xu
Journal:  Exp Ther Med       Date:  2017-08-08       Impact factor: 2.447

Review 7.  Clinical use of telemonitoring in chronic heart failure: keeping up with the times or misuse of time?

Authors:  Nik Stoyanov; Vince Paul
Journal:  Curr Heart Fail Rep       Date:  2012-03

8.  Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk.

Authors:  O W Nielsen; J Hilden; C T Larsen; J F Hansen
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

9.  Patients' self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death.

Authors:  Richard Holland; Boika Rechel; Karolina Stepien; Ian Harvey; Iain Brooksby
Journal:  J Card Fail       Date:  2009-10-22       Impact factor: 5.712

10.  Risk factors for mortality in users of ibopamine.

Authors:  J Feenstra; B A in't Veld; P D van der Linden; D E Grobbee; B H Stricker
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.